Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pervasive and programmed nucleosome distortion on single chromatin fibres.

Nature·2026

Same author

Type 2 lymphocytes restrict type 3 lymphocytes during liver fibrosis and colocalize in fibroblast niches.

Science advances·2026

Same author

Immune profiling links autoimmune hepatitis to human herpesvirus 6 and relaxin receptor antigens.

The Journal of experimental medicine·2026

Same author

Predicting metabolic dysfunction-associated steatotic liver disease risk using patient-derived induced pluripotent stem cells.

Stem cells translational medicine·2026

Same author

Loss of function of T-box 3 in the liver protects against MASLD.

The Journal of clinical investigation·2025

Same author

iPSC-Derived Hepatocytes from Patients with MASLD Exhibit Early Mitochondrial Dysfunction.

bioRxiv : the preprint server for biology·2025

Search research articles

Related Experiment Video

Updated: Jan 9, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Modeling Familial MASH by iPSC-Hepatocytes.

Cristina Esteva-Font, Jacquelyn J Maher, Eric Rulifson

Medrxiv : the Preprint Server for Health Sciences

|December 3, 2025

Summary

This summary is machine-generated.

Researchers used induced hepatocytes (iHeps) from families with genetic metabolic dysfunction-associated steatohepatitis (MASH) to create a better preclinical model. This approach revealed disease complexity and the power of iHeps for studying human liver conditions.

More Related Videos

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes

Published on: October 10, 2025

Related Experiment Videos

Last Updated: Jan 9, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes

Published on: October 10, 2025

Area of Science:

Hepatology
Stem Cell Biology
Genetics

Background:

Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progression to metabolic dysfunction-associated steatohepatitis (MASH) are increasing due to obesity.
MASH can lead to inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma.
Current preclinical models, including cell lines and mouse models, do not accurately replicate human MASH pathogenesis.

Purpose of the Study:

To develop a faithful preclinical platform for studying human genetic MASH.
To characterize MASH pathogenesis using patient-derived induced hepatocytes (iHeps).

Main Methods:

Identified families with genetic MASH predisposition.
Reprogrammed patient skin fibroblasts into induced pluripotent stem cells (iPSCs).
Differentiated iPSCs into hepatocytes (iHeps) for disease modeling and analysis of steatosis, apoptosis, mitochondrial function, and ER stress.

Main Results:

MASH family iHeps exhibited increased baseline steatosis compared to control iHeps.
Whole exome sequencing identified single nucleotide polymorphisms (SNPs) of unclear significance in MASH patients.
Patients were heterozygous for the TM6SF2 E167K SNP, a finding explored in iHeps.

Conclusions:

Human genetic MASH is complex.
Patient-derived iHeps provide a powerful tool for characterizing complex human liver diseases like MASH.
This study highlights the potential of iHeps for advancing MASH research and drug development.